| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 09.05. | Earnings call: Aclaris Therapeutics progresses with atopic dermatitis study | 3 | Investing.com | ||
| 08.05. | Aclaris Therapeutics falls as Q1 revenue declines | 2 | Reuters | ||
| 07.05. | Aclaris Therapeutics Inc reports results for the quarter ended in January - Earnings Summary | 2 | Reuters | ||
| 07.05. | Aclaris Therapeutics, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 07.05. | Aclaris Therapeutics, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
| 19.03. | Aclaris Therapeutics, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
| 27.02. | Aclaris Therapeutics, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
| 27.02. | Aclaris Therapeutics GAAP EPS of -$0.02 beats by $0.31, revenue of $17.6M beats by $12.55M | 3 | Seeking Alpha | ||
| 27.02. | Aclaris Therapeutics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 27.02. | Aclaris Therapeutics, Inc.: Aclaris Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update | 2 | GlobeNewswire (USA) | ||
| 05.02. | Aclaris Therapeutics, Inc. - 8-K, Current Report | 6 | SEC Filings | ||
| 23.01. | HW Wainwright cuts Aclaris to neutral, cites underwhelming study data | 10 | Seeking Alpha | ||
| 22.01. | Aclaris Therapeutics' ATI-1777 Faces Uphill Battle In Atopic Dermatitis Treatment Landscape, Analyst Downgrades | 2 | Benzinga.com | ||
| 19.01. | Aclaris Therapeutics, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
| 17.01. | Aclaris (ACRS) Stock Rises on Appointment of New Interim CEO | 4 | Zacks | ||
| 16.01. | Why Is Dermatology Focused Aclaris Therapeutics Stock Trading Higher Today? | 5 | Benzinga.com | ||
| 16.01. | Aclaris spikes after leadership change, strategic review | 10 | Seeking Alpha | ||
| 11.01. | The Analyst Landscape: 4 Takes On Aclaris Therapeutics | 6 | Benzinga.com | ||
| 11.01. | Aclaris (ACRS) Down 21% on Mixed Results From Eczema Study | 1 | Zacks | ||
| 11.01. | Aclaris draws second downgrade despite Phase 2 win for eczema therapy | 3 | Seeking Alpha |
Seite:
1 2 3 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| GAMESTOP | 2.858 |
| EVOTEC | 2.612 |
| TUI | 1.953 |
| NVIDIA | 1.684 |
| NEL | 1.404 |
| BAYER | 1.256 |
| SIEMENS ENERGY | 1.226 |
| PLUG POWER | 1.150 |
| RHEINMETALL | 1.129 |
| REDCARE PHARMACY | 902 |
| BYD | 884 |
| AIXTRON SE | 869 |
| DEUTSCHE BANK | 848 |
| COMMERZBANK | 823 |
| VOLKSWAGEN | 806 |
| RENK GROUP | 787 |
| MERCEDES-BENZ | 773 |
| AMC ENTERTAINMENT | 772 |
| DEUTSCHE LUFTHANSA | 728 |
| BARRICK GOLD | 703 |
| HEIDELBERGER DRUCK | 629 |
| SUPER MICRO COMPUTER | 618 |
| RWE | 591 |
| TESLA | 586 |
| BASF | 582 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
